To determine whether CYLD exerts a similar effect on tumor-intrinsic chemokine production as SPATA2, we transiently knocked down CYLD by RNAi and measured CXCL9, CXCL10, and CXCL11 secretion. The gene discussed is CYLD; the disease is neoplasm.